Skip to content
Are all viral vector vaccines a problem? episode artwork

Apr 14, 2021 11 min

Are all viral vector vaccines a problem?

from What's That Rash? Hosted by Australian Broadcasting Corporation

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a taxi to deliver a bit of coronavirus to help teach the immune system. So on today's Coronacast, what are viral vector vaccines and could the rare blood-clots be a problem with them more broadly? Also on today's show: * What do the data show regarding the risks of clotting for people over the age of 50? * What can we learn from the US vaccine rollout? (We hear from special guest Anthony Fauci, who Tegan interviewed as part of an event presented by UNSW)

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Are all viral vector vaccines a problem?

0:00 11:14

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of What's That Rash??

This episode is 11 minutes long.

When was this What's That Rash? episode published?

This episode was published on April 14, 2021.

Can I download this What's That Rash? episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.